[HTML][HTML] Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and-resistant prostate cancer
W Qi, C Morales, LS Cooke, B Johnson, B Somer… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Gain-of-function of the androgen receptor (AR) and activation of PI3K/AKT/mTOR pathway
have been demonstrated to correlate with progression to castration-resistant prostate cancer …
have been demonstrated to correlate with progression to castration-resistant prostate cancer …
[PDF][PDF] Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and-resistant prostate cancer
W Qi, C Morales, LS Cooke, B Johnson, B Somer… - researchgate.net
Gain-of-function of the androgen receptor (AR) and activation of PI3K/AKT/mTOR pathway
have been demonstrated to correlate with progression to castrationresistant prostate cancer …
have been demonstrated to correlate with progression to castrationresistant prostate cancer …
Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and-resistant prostate cancer
W Qi, C Morales, LS Cooke, B Johnson… - …, 2015 - pubmed.ncbi.nlm.nih.gov
Gain-of-function of the androgen receptor (AR) and activation of PI3K/AKT/mTOR pathway
have been demonstrated to correlate with progression to castration-resistant prostate cancer …
have been demonstrated to correlate with progression to castration-resistant prostate cancer …
Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and-resistant prostate cancer
W Qi, C Morales, LS Cooke, B Johnson… - …, 2015 - legacy.oncotarget.com
Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for
castrate-sensitive and -resistant prostate cancer | Oncotarget Online ISSN: 1949-2553 Search …
castrate-sensitive and -resistant prostate cancer | Oncotarget Online ISSN: 1949-2553 Search …
[PDF][PDF] Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and-resistant prostate cancer
W Qi, C Morales, LS Cooke, B Johnson, B Somer… - pdfs.semanticscholar.org
Gain-of-function of the androgen receptor (AR) and activation of PI3K/AKT/mTOR pathway
have been demonstrated to correlate with progression to castrationresistant prostate cancer …
have been demonstrated to correlate with progression to castrationresistant prostate cancer …
Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and-resistant prostate cancer
W Qi, C Morales, LS Cooke, B Johnson… - …, 2015 - mdanderson.elsevierpure.com
Gain-of-function of the androgen receptor (AR) and activation of PI3K/AKT/mTOR pathway
have been demonstrated to correlate with progression to castrationresistant prostate cancer …
have been demonstrated to correlate with progression to castrationresistant prostate cancer …
Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and-resistant prostate cancer
W Qi, C Morales, LS Cooke, B Johnson, B Somer… - …, 2015 - scholars.uthscsa.edu
Gain-of-function of the androgen receptor (AR) and activation of PI3K/AKT/mTOR pathway
have been demonstrated to correlate with progression to castrationresistant prostate cancer …
have been demonstrated to correlate with progression to castrationresistant prostate cancer …
[HTML][HTML] Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and-resistant prostate cancer
W Qi, C Morales, LS Cooke, B Johnson, B Somer… - Oncotarget, 2015 - oncotarget.com
Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for
castrate-sensitive and -resistant prostate cancer | Oncotarget Online ISSN: 1949-2553 Search …
castrate-sensitive and -resistant prostate cancer | Oncotarget Online ISSN: 1949-2553 Search …
Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and-resistant prostate cancer.
W Qi, C Morales, LS Cooke, B Johnson, B Somer… - Oncotarget, 2015 - europepmc.org
Gain-of-function of the androgen receptor (AR) and activation of PI3K/AKT/mTOR pathway
have been demonstrated to correlate with progression to castration-resistant prostate cancer …
have been demonstrated to correlate with progression to castration-resistant prostate cancer …
Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and-resistant prostate cancer.
W Qi, C Morales, LS Cooke, B Johnson, B Somer… - Oncotarget, 2015 - europepmc.org
Gain-of-function of the androgen receptor (AR) and activation of PI3K/AKT/mTOR pathway
have been demonstrated to correlate with progression to castration-resistant prostate cancer …
have been demonstrated to correlate with progression to castration-resistant prostate cancer …